Psychiatry - Neuro/Psych Pharmacol News & Articles

181 Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia International Journal of Neuropsychopharmacology, March 11, 2013    Clinical Article

182 Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study Asian Journal of Psychiatry, March 8, 2013    Clinical Article

183 Serial infusions of low-dose ketamine for major depression Journal of Psychopharmacology, March 8, 2013    Clinical Article

184 Blonanserin for the treatment of delirium patients at an emergency medical care center: An open-label study Asian Journal of Psychiatry, March 8, 2013    Clinical Article

185 The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia Current Medical Research and Opinion, March 8, 2013    Clinical Article

186 Methylphenidate Normalizes Resting-State Brain Dysfunction in Boys With Attention Deficit Hyperactivity Disorder Neuropsychopharmacology, March 8, 2013    Clinical Article

187 Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: Focus on clinical efficacy and safety Journal of Psychopharmacology, March 7, 2013    Evidence Based Medicine    Review Article    Clinical Article

188 Eliminating the Inappropriate use of Antipsychotics in Residents with Dementia by Using a Multidisciplinary Pharmacy and Therapeutics (P&T) Committee Journal of the American Medical Directors Association, March 7, 2013    Review Article

189 Dopamine D 4 receptor gene variation is associated with context-dependent attention for emotion stimuli International Journal of Neuropsychopharmacology, March 7, 2013    Clinical Article

190 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013    Clinical Article

191 Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES) International Journal of Neuropsychopharmacology, March 6, 2013    Review Article

192 Role of the cholinesterase inhibitors in the treatment of schizophrenia Expert Opinion on Investigational Drugs, March 6, 2013    Clinical Article

193 Life-threatning haematemesis associated with clozapine: a case report and literature review Therapeutic Advances in Psychopharmacology, March 6, 2013    Review Article    Clinical Article

194 Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia Current Medical Research and Opinion, March 5, 2013    Clinical Article

195 The Effect of Race-Ethnicity on the Comparative Effectiveness of Clozapine Among Medicaid Beneficiaries Psychiatric Services, March 4, 2013    Clinical Article

196 Use of Varenicline vs Bupropion and Risk of Psychiatric Adverse Events Addiction, March 1, 2013    Clinical Article

197 Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate Full Text BMC Psychiatry, February 28, 2013    Clinical Article

198 Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects Clinical Schizophrenia & Related Psychoses, February 28, 2013    Clinical Article

199 A systematic review of the evidence on the treatment of rapid cycling bipolar disorder Bipolar Disorders, February 28, 2013    Evidence Based Medicine    Review Article    Clinical Article

200 Psychomotor depressive symptoms may differentially respond to venlafaxine International Clinical Psychopharmacology, February 28, 2013    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013